Table 3 Leukemia subtype, risk status, and treatment details.

From: The triponderal mass index as a measure of adiposity in pediatric survivors of acute lymphoblastic leukemia: a cross-sectional study

Variables

Frequency (n, %)

n = 113

Males (n, %)

n = 58

Females (n, %)

n = 55

Leukemia subtype

B cell

102 (90.20)

49 (84.50)

53 (96.40)

T cell

11 (9.80)

9 (15.50)

2 (3.60)

Risk status

Standard Risk

78 (69.00)

34 (58.60)

44 (80.00)

Intermediate Risk

1 (0.90)

1 (1.70)

0

High Risk

32 (28.30)

22 (37.90)

10 (18.20)

Very High Risk

2 (1.80)

1 (1.70)

1 (1.80)

Treatment protocol

DFCI 11–001

25 (22.10)

12 (20.70)

13 (23.60)

DFCI 05–001

77 (68.20)

42 (72.40)

35 (63.60)

DFCI 2000–01

11 (9.70)

4 (6.90)

7 (12.70)

  1. ALL Acute Lymphoblastic Leukemia, DFCI Dana Farber Cancer Institute Protocol.